DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at StockNews.com

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a hold rating to a buy rating in a research note published on Tuesday morning.

XRAY has been the subject of a number of other research reports. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Evercore ISI reissued an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price for the company. Finally, Morgan Stanley dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Ten equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $25.85.

DENTSPLY SIRONA Trading Down 0.2 %

Shares of XRAY stock opened at $18.95 on Tuesday. The firm has a market cap of $3.77 billion, a P/E ratio of -9.15, a PEG ratio of 1.79 and a beta of 0.96. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $34.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm’s 50-day simple moving average is $18.94 and its 200-day simple moving average is $21.75.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.38%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -30.92%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently made changes to their positions in the business. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Capital Performance Advisors LLP purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $27,000. MassMutual Private Wealth & Trust FSB boosted its stake in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.